NEIL2 and non-small cell lung carcinoma: These findings are also consistent with our clinical observation that the expression level of NEIL2 protein was significantly higher in NSCLC patients bearing “C/C” homozygous and “T/C” heterozygous than in “T/T” homozygote patients.